Tumor cytosol carcinoembryonic antigen as prognostic parameter in non-small cell lung cancer

Tumori

Volumn 88, Issue 2, 2002, Pages 142-146

  Vegh, Irene ^a   Sotelo, Teresa ^a   Estenoz, Juana ^a   Fontanellas, Antonio ^a   Navarro, Susana ^a   Millán, Isabel ^a   De Salamanca, Rafael Enríquez ^a  

^a Hospital Universitario   (Spain)

Author keywords

cCEA; Lymph node metastases; NSCLC; Tumor marker

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BLOOD LEVEL; CELL LEVEL; CLINICAL ARTICLE; CYTOPLASM; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUMINESCENCE; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MALE; PROGNOSIS; RADIOIMMUNOASSAY; TUMOR VOLUME;

EID: 0036274670     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160208800212     Document Type: Article

References (31)

1. Demonstration of tumor-specific antigens in human colonic carcinoma by immunological tolerance and absorption techniques
2. Clinical applications of serum tumor markers. Review
3. Further investigations of immunoreactive carcino-embryonic antigen (CEA) in colorectal cancer patients with particular emphasis on the correlation between immunoreactive CEA levels in tissue, feces and blood
4. Use of carcinoembryonic antigen in small cell lung cancer. Prognostic value and relation to the clinical course
5. Expression of CEA and trophoblastic cell markers by lung carcinoma in association with histological characteristics and serum marker levels
6. Carcinoembryonic antigen in 228 patients with carcinoma of the lung
7. Contents of tissue CEA and CA 19.9 in colonic polyp and colorectal cancer, and their clinical significance
8. Carcinoembryonic antigen in patients with different cancers
9. Factors controlling the circulating CEA levels in pancreatic cancer: Some clinical correlations
10. Immunohistochemical localization of placental alkaline phosphatase, carcinoembryonic antigen, and cancer antigen 125 in normal and neoplastic human lung
11. Quantitative analysis of carcinoembryonic antigen, squamous cell carcinoma antigen, CA 125, and CA 50 cytosolic content in non small cell lung carcinoma
12. Immunohistochemical localization of carcinoembryonic antigen (CEA), CEA-s, and non-specific cross-reacting antigen (NCA) in carcinomas of lung
13. Histological typing of lung cancer
14. Colorectal cancer survival: Possible prognostic value of tissular carbohydrate antigen CA19.9 determinations
15. Clinical value of a multiple biomarker assay in patients with bronchogenic carcinoma
16. Preoperative carcinoembryonic antigen level as a prognostic indicator in resected primary lung cancer
17. Evaluation of tissue polypeptide specific antigen, CYFRA 21-1, and carcinoembryonic antigen in non-small cell lung carcinoma: Does the combined use of cytokeratin markers give any additional information?
18. The value of tumour markers in lung cancer
19. Non-small lung cancer (NSCLC): Prognostic value of the expression of p53, bcl-2, c-erB2, ADN ploidy and S- phase cell fraction
20. Carcinoembryonic antigen and steroid receptors in cytosol of carcinoma of the breast. Relationship to pathologic and clinical features
21. Characteristics of carcinoembryonic antigen (CEA) expressed in different cell types: Evidence that CEA can function as an adhesion molecule and as a repulsion molecule
22. Metastatic potential of human colon cancer cell lines: Relationship to cellular differentiation and carcinoembryonic antigen production
23. Carcinoembryonic antigen, a human tumour marker, functions as an intracellular adhesion molecule
24. Carcinoembryonic antigen: Function in metastasis by human colorectal carcinoma
25. Carcinoembryonic antigen as a selective enhancer of colorectal cancer metastasis
26. Expression of transduced carcino-embryonic antigen gene in human rhabdomyosarcoma inhibits metastasis
27. Opposite functions for two classes of genes of the human carcinoembryonic antigen family
28. Carcinoembryonic antigen, a human tumor marker, co-operates with Myc and Bcl-2 in cellular transformation
29. Tumour markers CEA, NSE, SCC, TPA and CYFRA 21.1 in resectable non small cell lung cancer
30. Role of serum tumor markers CA125 and CEA in nonsmall-cell lung cancer